<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cancer types</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>US cancer screening rates decline over the last 10 years, study finds</title>
   	 <description>The rate of people who seek preventive cancer screenings has fallen over the last ten years in the United States with wide variations between white-collar and blue-collar workers, according to a University of Miami Miller School of Medicine study published on December 27 in the open-access journal Frontiers in Cancer Epidemiology.</description>
     <link>http://medicalxpress.com/news/2012-12-cancer-screening-decline-years.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Dec 2012 02:00:01 EST</pubDate>
	 <guid isPermaLink="false">news275757596</guid>
	 
</item>
<item>
     <title>Phase III worldwide study of new drug for patients with pancreatic cancer</title>
   	 <description>A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).</description>
     <link>http://medicalxpress.com/news/2012-11-phase-iii-worldwide-drug-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 19 Nov 2012 13:14:23 EST</pubDate>
	 <guid isPermaLink="false">news272553254</guid>
	 
</item>
<item>
     <title>Awareness could eliminate inequalities in cancer diagnoses</title>
   	 <description>There are substantial inequalities in the stage at which cancer patients receive their diagnosis – a critical factor for cancer survival – a new study by the University of Cambridge reveals. The researchers found that age, sex and income as well as the type of cancer influenced the risk of a patient being diagnosed at an advanced stage of the disease. Eliminating these inequalities would help improve the chances of a cure for up to 5,600 patients with seven common cancers each year. The research was published today in the Annals of Oncology.</description>
     <link>http://medicalxpress.com/news/2012-11-awareness-inequalities-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Nov 2012 23:00:01 EST</pubDate>
	 <guid isPermaLink="false">news271955396</guid>
	 
</item>
<item>
     <title>Statin use at cancer diagnosis linked to lower mortality</title>
   	 <description>(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-11-statin-cancer-diagnosis-linked-mortality.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Nov 2012 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news271593372</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/statinuseatc.jpg" width="90" height="90" />
</item>
<item>
     <title>Unmasking the deadly secrets of pancreatic cancer</title>
   	 <description>(Medical Xpress)—A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature.</description>
     <link>http://medicalxpress.com/news/2012-10-unmasking-deadly-secrets-pancreatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 25 Oct 2012 10:15:08 EST</pubDate>
	 <guid isPermaLink="false">news270378881</guid>
	 
</item>
<item>
     <title>Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice</title>
   	 <description>In what they say is a promising and highly selective treatment strategy, scientists at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are &quot;addicted,&quot; according to a new study.</description>
     <link>http://medicalxpress.com/news/2012-10-cancers-addiction-cell-cycle-proteins-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Oct 2012 14:56:57 EST</pubDate>
	 <guid isPermaLink="false">news269618209</guid>
	 
</item>
<item>
     <title>Myths and misunderstandings hamper efforts to prevent cancer</title>
   	 <description>New insights on the global fight to prevent cancers were presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The studies highlight the challenges of overcoming misunderstandings about how important lifestyle factors are in reducing cancer risk.</description>
     <link>http://medicalxpress.com/news/2012-09-myths-hamper-efforts-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 30 Sep 2012 06:08:03 EST</pubDate>
	 <guid isPermaLink="false">news268204071</guid>
	 
</item>
<item>
     <title>Aggressive cancer exploits MYC oncogene to amplify global gene activity</title>
   	 <description>Whitehead Institute researchers have determined the mechanism used by c-Myc to increase the expression of all active genes in cancer cells. Elevated levels of c-Myc are linked to increased rates of metastasis, disease recurrence, and mortality in cancer patients. Guided by this new model, researchers hope to find ways to restrict c-Myc's activity to eradicate cancer cells that become dependent on c-Myc for their survival.</description>
     <link>http://medicalxpress.com/news/2012-09-aggressive-cancer-exploits-myc-oncogene.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Sep 2012 12:00:08 EST</pubDate>
	 <guid isPermaLink="false">news267964972</guid>
	 
</item>
<item>
     <title>Major cancer protein amplifies global gene expression</title>
   	 <description>Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.</description>
     <link>http://medicalxpress.com/news/2012-09-major-cancer-protein-amplifies-global.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 27 Sep 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news267965344</guid>
	 
</item>
<item>
     <title>Prostate cancer diagnosis and surgery can lead to anxiety, depression and reduced quality of life</title>
   	 <description>Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers at Mayo Clinic's campus in Florida. Their recent study, published in the online edition of Psycho-Oncology, suggests that men who experience high levels of &quot;cancer-specific anxiety&quot; following surgery for prostate cancer could likely benefit from counseling designed to address their worries and improve their quality of life.</description>
     <link>http://medicalxpress.com/news/2012-09-prostate-cancer-diagnosis-surgery-anxiety.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 24 Sep 2012 15:59:33 EST</pubDate>
	 <guid isPermaLink="false">news267721118</guid>
	 
</item>
<item>
     <title>Reseach reveals genomic similarities between breast cancer, ovarian cancers</title>
   	 <description>One subtype of breast cancer shares many genetic features with high-grade serous ovarian cancer, a cancer that is very difficult to treat, according to researchers supported by the National Institutes of Health. The findings suggest that the two cancers are of similar molecular origin, which may facilitate the comparison of therapeutic data for subtypes of breast and ovarian cancers.</description>
     <link>http://medicalxpress.com/news/2012-09-reseach-reveals-genomic-similarities-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 23 Sep 2012 13:00:16 EST</pubDate>
	 <guid isPermaLink="false">news267601719</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/14-studyreveals.jpg" width="90" height="90" />
</item>
<item>
     <title>Light drinking may relate to increase in risk for certain cancers</title>
   	 <description>The majority of observational studies have shown that alcohol intake, especially heavy drinking, increases a number of upper-aero-digestive tract (UADT) and other cancers, and even moderate drinking is associated with a slight increase in the risk of breast cancer. A meta analysis published in the Annals of Oncology compares the effects between light drinkers (an average reported intake of up to 1 typical drink/day) versus &quot;non-drinkers&quot; in terms of relative risks for a number of types of cancer.</description>
     <link>http://medicalxpress.com/news/2012-09-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 18 Sep 2012 11:11:31 EST</pubDate>
	 <guid isPermaLink="false">news267185483</guid>
	 
</item>
<item>
     <title>Cloned receptor paves way for new breast and prostate cancer treatment</title>
   	 <description>Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study is being published this week in PNAS.</description>
     <link>http://medicalxpress.com/news/2012-09-cloned-receptor-paves-breast-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Sep 2012 13:06:40 EST</pubDate>
	 <guid isPermaLink="false">news266760374</guid>
	 
</item>
<item>
     <title>Study identifies human melanoma stem cells</title>
   	 <description>(Medical Xpress)—Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed a tumor. These stem cells resist chemotherapy and many researchers posit their role in relapse. A University of Colorado Cancer Center study recently published in the journal Stem Cells, shows that melanoma cells with these abilities are marked by the enzyme ALDH, and imagines new therapies to target high-ALDH cells, potentially weeding the body of these most dangerous cancer creators.</description>
     <link>http://medicalxpress.com/news/2012-08-human-melanoma-stem-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 23 Aug 2012 15:20:02 EST</pubDate>
	 <guid isPermaLink="false">news264953220</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/4-studyidentif.jpg" width="90" height="86" />
</item>
<item>
     <title>Cancer survival in Germany after the fall of the Iron Curtain</title>
   	 <description>Data from the 1970s and 1980s show that people affected by cancer survived significantly longer in West Germany than cancer patients behind the Iron Curtain. Looking at a diagnosis period from 1984 to 1985 in the former German Democratic Republic, 28 percent of colorectal cancer patients, 46 percent of prostate cancer patients, and 52 percent of breast cancer patients survived the first five years after diagnosis. By contrast, 5-year survival rates for people in West Germany affected by these types of cancer were 44 percent, 68 percent, and 68 percent in the years from 1979 to 1983 already.</description>
     <link>http://medicalxpress.com/news/2012-08-cancer-survival-germany-fall-iron.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 23 Aug 2012 13:10:01 EST</pubDate>
	 <guid isPermaLink="false">news264945156</guid>
	 
</item>
<item>
     <title>Heat-shock factor reveals its unique role in supporting highly malignant cancers</title>
   	 <description>Whitehead Institute researchers have found that increased expression of a specific set of genes is strongly associated with metastasis and death in patients with breast, colon, and lung cancers. Not only could this finding help scientists identify a gene profile predictive of patient outcomes and response to treatment, it could also guide the development of therapeutics to target multiple cancer types.</description>
     <link>http://medicalxpress.com/news/2012-08-heat-shock-factor-reveals-unique-role.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Aug 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news263127408</guid>
	 
</item>
<item>
     <title>Genomic study shows colon and rectal tumors constitute a single type of cancer</title>
   	 <description>The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer Genome Atlas (TCGA) project's large-scale study of colon and rectal cancer tissue specimens.</description>
     <link>http://medicalxpress.com/news/2012-07-genomic-colon-rectal-tumors-constitute.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Jul 2012 13:00:26 EST</pubDate>
	 <guid isPermaLink="false">news261826077</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genomicstudy.jpg" width="90" height="99" />
</item>
<item>
     <title>'Master switch' experimental drug could treat different cancers</title>
   	 <description>(Medical Xpress) -- A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today.</description>
     <link>http://medicalxpress.com/news/2012-07-master-experimental-drug-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 Jul 2012 09:18:48 EST</pubDate>
	 <guid isPermaLink="false">news261217120</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cr_088967.jpg" width="90" height="90" />
</item>
<item>
     <title>No therapy for 20 percent with stage IV solid tumors</title>
   	 <description>(HealthDay) -- About 20 percent of patients diagnosed with stage IV metastatic solid tumors do not receive anticancer treatment, according to a study published online June 15 in Cancer.</description>
     <link>http://medicalxpress.com/news/2012-06-therapy-percent-stage-iv-solid.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 23 Jun 2012 06:58:31 EST</pubDate>
	 <guid isPermaLink="false">news259653498</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/notherapyfor.jpg" width="90" height="90" />
</item>
<item>
     <title>New drugs, new ways to target androgens in prostate cancer therapy</title>
   	 <description>Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects.</description>
     <link>http://medicalxpress.com/news/2012-06-drugs-ways-androgens-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 20 Jun 2012 12:59:54 EST</pubDate>
	 <guid isPermaLink="false">news259415977</guid>
	 
</item>
<item>
     <title>A new indicator for breast cancer relapse identified</title>
   	 <description>Researchers at the IMIM (Institut de Recerca Hospital del Mar) have proven that the absence of the 14-3-3 protein sigma in breast cancer cells is directly associated with these cells' capacity to activate the signalling of a protein complex called NF-kB, which is related to tumour progression. The activation of NF-kB in tumours was also identified as the best indicator for relapse in breast cancer patients, compared to other parameters currently used, such as the presence of affected ganglions or the tumour's size and degree. The investigators have also described a group of genes that are activated in breast cancer cells and that are also associated with a poor prognosis in other types of tumours.</description>
     <link>http://medicalxpress.com/news/2012-06-indicator-breast-cancer-relapse.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 19 Jun 2012 10:28:40 EST</pubDate>
	 <guid isPermaLink="false">news259320513</guid>
	 
</item>
<item>
     <title>ASCO: Continuing avastin with 2nd-line chemo ups survival</title>
   	 <description>(HealthDay) -- Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy, according to the results of a phase III study presented at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.</description>
     <link>http://medicalxpress.com/news/2012-06-asco-avastin-2nd-line-chemo-ups.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Jun 2012 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258120168</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ascocontinui.jpg" width="90" height="90" />
</item>
<item>
     <title>Dabrafenib shrinks melanoma brain metastases in phase I clinical trial</title>
   	 <description>An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.</description>
     <link>http://medicalxpress.com/news/2012-05-dabrafenib-melanoma-brain-metastases-phase.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 May 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news256493208</guid>
	 
</item>
<item>
     <title>Physical activity linked to reduced mortality in breast and colon cancer patients</title>
   	 <description>Physical activity is associated with reduced breast and colon cancer mortality, but there is insufficient evidence on the association for other cancer types, according to a study published May 8 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-05-physical-linked-mortality-breast-colon.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 08 May 2012 16:00:15 EST</pubDate>
	 <guid isPermaLink="false">news255696645</guid>
	 
</item>
<item>
     <title>Doctors urge routine skin screenings</title>
   	 <description>(HealthDay) -- Adults and children should be screened routinely for changes in the appearance of their skin, experts advise.</description>
     <link>http://medicalxpress.com/news/2012-05-doctors-urge-routine-skin-screenings.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 07 May 2012 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news255605191</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/doctorsurger.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers discover a DNA marker that indicates if ovarian cancer treatment will be successful</title>
   	 <description>Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer. More specifically, a genetic marker embedded in deoxyribonucleic acid (DNA), called microRNA, indicates if a patient with ovarian cancer has a benign or cancerous tumor, and that she will benefit from chemotherapy after surgery on the tumor. This data will be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held from Saturday through Wednesday (March 31- April 4) in Chicago, IL.</description>
     <link>http://medicalxpress.com/news/2012-04-dna-marker-ovarian-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 16:09:14 EST</pubDate>
	 <guid isPermaLink="false">news252688146</guid>
	 
</item>
<item>
     <title>Nearly half of cancer survivors died from conditions other than cancer</title>
   	 <description>Although cancer recurrence may be the overriding fear for many survivors, nearly half of survivors from a recently presented study died from other conditions.</description>
     <link>http://medicalxpress.com/news/2012-04-cancer-survivors-died-conditions.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news252684211</guid>
	 
</item>
<item>
     <title>Protein Aurora-A is found to be associated with survival in head and neck cancer</title>
   	 <description>Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments. The findings will be reported at the AACR Annual Meeting 2012 on Sunday, April 1.</description>
     <link>http://medicalxpress.com/news/2012-04-protein-aurora-a-survival-neck-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 01 Apr 2012 14:40:20 EST</pubDate>
	 <guid isPermaLink="false">news252510005</guid>
	 
</item>
<item>
     <title>Few young women with cancer take steps to preserve fertility during treatments</title>
   	 <description>A new study has found that very few young women with cancer take steps to preserve their fertility while undergoing cancer therapy. Also, certain groups of young women are more likely to do so than others. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to provide counseling on fertility preservation in reproductive-aged women diagnosed with cancer.</description>
     <link>http://medicalxpress.com/news/2012-03-young-women-cancer-fertility-treatments.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Mar 2012 04:59:59 EST</pubDate>
	 <guid isPermaLink="false">news251956785</guid>
	 
</item>
<item>
     <title>Study shows colorectal cancer screening rates high in patients with multiple health problems</title>
   	 <description>A study by University of Kentucky researchers showed that in Appalachia, colorectal cancer screening rates were higher in the population with multiple morbidities or diseases compared to those who had no morbidities at all.</description>
     <link>http://medicalxpress.com/news/2012-03-colorectal-cancer-screening-high-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 20 Mar 2012 15:52:38 EST</pubDate>
	 <guid isPermaLink="false">news251477520</guid>
	 
</item>


</channel>
</rss>
